Amedeo Smart

Free Medical Literature Service


 

Amedeo

Dermatology

  Free Subscription

03.02.2025

13 Am J Dermatopathol
5 BMC Cancer
12 Br J Dermatol
2 Cancer
18 Clin Exp Dermatol
4 Cutis
1 Int J Cancer
9 Int J Dermatol
2 J Dermatol
5 J Invest Dermatol
2 Mycoses
2 N Engl J Med
1 Nat Rev Cancer
3 Plast Reconstr Surg
11 PLoS One
2 Proc Natl Acad Sci U S A



    Am J Dermatopathol

  1. HAMMACK MA, Mansfield PK, Tinker D, Chow P, et al
    Eruptive Widespread Violaceous Papules and Nodules on the Trunk: Answer.
    Am J Dermatopathol. 2025;47:153-154.
    >> Share

  2. SANDOVAL-GARCES M, Moneva-Leniz LM, Barrientos-Fernandez B
    Long-Standing Generalized Erythematous-Violaceous Papules: Answer.
    Am J Dermatopathol. 2025;47:158-159.
    >> Share

  3. HAMMACK MA, Mansfield PK, Tinker D, Chow P, et al
    Eruptive Widespread Violaceous Papules and Nodules on the Trunk: Challenge.
    Am J Dermatopathol. 2025;47:e12-e14.
    >> Share

  4. SANDOVAL-GARCES M
    Long-Standing Generalized Erythematous-Violaceous Papules: Challenge.
    Am J Dermatopathol. 2025;47:e21-e22.
    >> Share

  5. TANG J, Lv B
    Subcutaneous Sweet Syndrome With Vasculitis Features: Case Report and Review.
    Am J Dermatopathol. 2025;47:133-137.
    >> Share

  6. COURTOIS A, Allaume P, Raby M, Pastoret C, et al
    Differential Expression of p53 in Mycosis Fungoides, Sezary Syndromes, and Their Transformed Forms.
    Am J Dermatopathol. 2025;47:95-104.
    >> Share

  7. NOCCO S, Magro C
    Primary Cutaneous Methotrexate-Associated T-Cell Lymphoproliferative Disorder in the Setting of Autoimmune Disease: A Case Series and Review of the Literature.
    Am J Dermatopathol. 2025;47:145-152.
    >> Share

  8. JOAO DA, Pancsa T, Kicko P, Langerova E, et al
    Secondary Syphilis Presenting With an Interstitial Granuloma Annulare-Like Histopathologic Pattern: A Report of 2 Cases.
    Am J Dermatopathol. 2025;47:122-127.
    >> Share

  9. SHAKER N, Alazawi S, Sangueza O
    Pigmented Syringomatous Carcinoma/Sweat Gland Carcinoma of the Vulva With Melanocytic Colonization: An Uncommon Presentation of a Rare Sweat Gland Neoplasm.
    Am J Dermatopathol. 2025;47:119-121.
    >> Share

  10. ABADJIEVA TI, Genova SN, Pencheva MM, Zhelyazkova ZH, et al
    Immunohistochemistry for Immunoglobulin G4 on Paraffin Sections as a Diagnostic Test for Pemphigus.
    Am J Dermatopathol. 2025;47:110-113.
    >> Share

  11. JACOBSON R, Kazmi M, Vaughan H, Agnihothri R, et al
    Direct Immunofluorescence in Dermatomyositis and Lupus Erythematosus: Cross-Sectional Diagnostic Accuracy and Correlation With Serologies and Other Features of Systemic Disease.
    Am J Dermatopathol. 2025;47:114-118.
    >> Share

  12. ARAN BM, Duran J, Gru AA
    A Case of Leukemia Cutis (Acute Myeloid Leukemia) With Epidermotropism.
    Am J Dermatopathol. 2025;47:141-144.
    >> Share

  13. SRIPODOK S, Wu NL, Wu YH
    Postautologous Hematopoietic Stem Cell Transplantation Disseminated Hypopigmented Keratosis.
    Am J Dermatopathol. 2025;47:138-140.
    >> Share


    BMC Cancer

  14. BHANGDIA K, Natarajan A, Rudolfson N, Verguet S, et al
    The association of travel distance and other patient characteristics with breast cancer stage at diagnosis and treatment completion at a rural Rwandan cancer facility.
    BMC Cancer. 2025;25:146.
    >> Share

  15. WANG Y, Wang R, Lu D, Zeng Y, et al
    Predictive factors for axillary pathological complete response to neoadjuvant therapy in elderly breast cancer patients.
    BMC Cancer. 2025;25:156.
    >> Share

  16. KAUTZ-FREIMUTH S, Shukri A, Stracke C, Isselhard A, et al
    Factors influencing role preferences in decision-making of healthy women with BRCA1/2 pathogenic variants: subanalysis from a randomised controlled decision coaching trial.
    BMC Cancer. 2025;25:164.
    >> Share

  17. GODIVEAU M, Passildas J, Thivat E, Casile M, et al
    Post-therapeutic support and rehabilitation for breast cancer women in complete remission in a thermal resort: study protocol for the PACThe Real-Life conditions observational trial.
    BMC Cancer. 2025;25:174.
    >> Share

  18. GETIE M, Mekonnen BA, Seifu D, Mulugeta Y, et al
    Serum cardiac and inflammatory biomarker levels following chemotherapy among female patients with breast cancer attending at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia.
    BMC Cancer. 2025;25:175.
    >> Share


    Br J Dermatol


  19. Correction to: Microbiome characterization of skin biopsies in Spanish patients with hidradenitis suppurativa shows a decrease in D1 and H1 lineages of Cutibacterium acnes.
    Br J Dermatol. 2025 Jan 24:ljaf029. doi: 10.1093.
    >> Share

  20. EGGERMONT CJ, Hollatz A, Wakkee M, Louwman M, et al
    Skin cancer risk in over 200.000 patients with haematologic malignancies in 30 years; a nationwide population-based study in the Netherlands.
    Br J Dermatol. 2025 Jan 24:ljaf027. doi: 10.1093.
    >> Share

  21. WARREN RB, Lebwohl M, Thaci D, Gooderham M, et al
    Bimekizumab efficacy and safety through 3 years in patients with moderate to severe plaque psoriasis: Long-term results from the BE RADIANT phase 3b trial open-label extension period.
    Br J Dermatol. 2025 Jan 25:ljaf032. doi: 10.1093.
    >> Share

  22. KANEDA E, Koguchi-Yoshioka H, Nimura K, Hattori S, et al
    Genotype-phenotype correlation for skin and neuropsychiatric features in tuberous sclerosis complex.
    Br J Dermatol. 2025 Jan 28:ljaf038. doi: 10.1093.
    >> Share

  23. GNIADECKI R
    Chaperoning a Cure: Unexpected Role of CD74 in Cutaneous T-cell lymphoma.
    Br J Dermatol. 2025 Jan 29:ljaf040. doi: 10.1093.
    >> Share

  24. ALVES C
    Orismilast for moderate-to-severe atopic dermatitis: the potential therapeutic value of a new oral pharmacological alternative.
    Br J Dermatol. 2025 Jan 30:ljaf042. doi: 10.1093.
    >> Share

  25. LEDUCQ S, Fong WCG, Williams HC, Bradshaw L, et al
    Reporting of concomitant and rescue topical therapies in atopic dermatitis randomised controlled trials evaluating a systemic treatment: a scoping review.
    Br J Dermatol. 2025 Jan 30:ljaf031. doi: 10.1093.
    >> Share

  26. PERALS C, le Jan S, Muller C, Le Naour R, et al
    Polarization of circulating follicular helper T cells correlates with bullous pemphigoid severity.
    Br J Dermatol. 2025;192:283-292.
    >> Share

  27. ZHU Z, Zhong X, Luo Z, Liu M, et al
    Global, regional and national burdens of acne vulgaris in adolescents and young adults aged 10-24 years from 1990 to 2021: a trend analysis.
    Br J Dermatol. 2025;192:228-237.
    >> Share

  28. GARG A, Burge R, Cohee A, Wallinger H, et al
    Validation of the real-world application of the Hidradenitis Suppurativa Quality of Life (HiSQOL) score to adults with hidradenitis suppurativa.
    Br J Dermatol. 2025;192:261-268.
    >> Share

  29. PILIANG M, Soung J, King B, Shapiro J, et al
    Efficacy and safety of the oral Janus kinase 3/tyrosine kinase expressed in hepatocellular carcinoma family kinase inhibitor ritlecitinib over 24 months: integrated analysis of the ALLEGRO phase IIb/III and long-term phase III clinical studies in alop
    Br J Dermatol. 2025;192:215-227.
    >> Share

  30. CHIU TM, Chen CB, Lu CW, Hui RC, et al
    CCR8/CCL1 and CXCR3/CXCL10 axis mediated memory T cell activations in recalcitrant drug-induced hypersensitivity patients.
    Br J Dermatol. 2024 Nov 6:ljae375. doi: 10.1093.
    >> Share


    Cancer

  31. MARCOTTE LM, Khor S, Reddy A, Morenz A, et al
    An analysis of multilevel factor contributions to breast cancer screening inequities in an academic health system.
    Cancer. 2025;131:e35734.
    >> Share

  32. WAKS AG, Tarantino P, Chen EL, Freedman RA, et al
    Outcomes and treatment patterns for stage I human epidermal growth factor receptor 2-positive breast cancer in the Surveillance, Epidemiology, and End Results database, 2010-2019.
    Cancer. 2025;131:e35729.
    >> Share


    Clin Exp Dermatol

  33. OGURA Y, Shimauchi T, Sugiyama T, Sugimura Y, et al
    A spectrum of BAP1 expression from nevus to melanoma in a patient with BAP1 tumor predisposition syndrome.
    Clin Exp Dermatol. 2025 Jan 25:llaf004. doi: 10.1093.
    >> Share

  34. PALANIAPPAN V, Karthikeyan K
    Lichen nitidus.
    Clin Exp Dermatol. 2025 Jan 30:llaf048. doi: 10.1093.
    >> Share

  35. PARK J, Cameron S, Flohr C, Choi M, et al
    Impact of Sensitive Skin on Quality of Life, Anxiety, and Depression: A Cross-Sectional Study.
    Clin Exp Dermatol. 2025 Jan 30:llaf028. doi: 10.1093.
    >> Share

  36. ALI OME, Haqiqi A, Salem R, Nasr B, et al
    A Case of a Blistering Eruption in Skin of Colour.
    Clin Exp Dermatol. 2025 Jan 31:llaf039. doi: 10.1093.
    >> Share

  37. JIN L, Yang J, Wan P, Cheng Y, et al
    Incidence trends of pediatric psoriasis in 1990-2021: findings from the Global Burden of Disease Study 2021.
    Clin Exp Dermatol. 2025 Jan 31:llaf050. doi: 10.1093.
    >> Share

  38. OLDHAM J, Tookey P, Morgan R, Ravindran S, et al
    Is a hybrid skin cancer surveillance service for organ transplant recipients feasible?: Lessons from the COVID-19 pandemic.
    Clin Exp Dermatol. 2025 Jan 31:llaf045. doi: 10.1093.
    >> Share

  39. HERCENT A, Bennani R, Lafitte P, Mary M, et al
    Clinical vs. molecular diagnosis of Gorlin syndrome: relevance of diagnostic criteria depends on the age of the patients.
    Clin Exp Dermatol. 2025;50:380-386.
    >> Share

  40. RASTGOO S, Mohammadi M, Maurer M, Atabaki M, et al
    Expression of STAT3, IL27p28 and IL12p35 is deregulated and linked to autoimmune markers in chronic spontaneous urticaria.
    Clin Exp Dermatol. 2025;50:357-364.
    >> Share

  41. DARCHINI-MARAGHEH E, Moussa A, Rees H, Jones L, et al
    Assessment of clinician-reported outcome measures for alopecia areata: a systematic scoping review.
    Clin Exp Dermatol. 2025;50:267-278.
    >> Share

  42. KEARNEY N, Chen X, Bi Y, Hew K, et al
    Treatment of hidradenitis suppurativa with adalimumab in the PIONEER I and II randomized controlled trials reduced indices of systemic inflammation, recognized risk factors for cardiovascular disease.
    Clin Exp Dermatol. 2025;50:339-347.
    >> Share

  43. VERRAN CD, Alexander MG, Shipman AR, Shipman KE, et al
    Interpretation of ferritin concentrations in the dermatology clinic.
    Clin Exp Dermatol. 2025;50:307-313.
    >> Share

  44. TAKEI S, Hayashi R, Hama N, Abe R, et al
    Cytomegalovirus complications in drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms: importance of routine monitoring and early therapeutic intervention.
    Clin Exp Dermatol. 2025;50:399-403.
    >> Share

  45. LALMALANI RM, Lim CXY, Oh CC
    Artificial intelligence in dermatopathology: a systematic review.
    Clin Exp Dermatol. 2025;50:251-259.
    >> Share

  46. DONOSO F, Peirano D, Aguero R, Longo C, et al
    Use of game-based learning strategies for dermatology and dermoscopy education: a cross-sectional survey of members of the International Dermoscopy Society.
    Clin Exp Dermatol. 2025;50:365-371.
    >> Share

  47. DOCHE I, Sotto MN, Hordinsky MK, Melhado IP, et al
    Hydroxychloroquine may be beneficial as an adjuvant therapy for folliculitis decalvans: a 5-year retrospective study with 49 patients.
    Clin Exp Dermatol. 2025;50:404-407.
    >> Share

  48. HENNING MAS, Barati F, Jemec GBE
    A systematic review and meta-analysis of psychiatric diseases in individuals with primary hyperhidrosis.
    Clin Exp Dermatol. 2025;50:323-330.
    >> Share

  49. SHI M, Wargon O, Tatian A
    Efficacy and safety of atenolol vs. propranolol for treatment of infantile haemangioma: a narrative review.
    Clin Exp Dermatol. 2025;50:331-338.
    >> Share

  50. ST GEORGE-HYSLOP F, Cherepacha N, Chugani B, Alabdeen Y, et al
    Drug-specific presentation and outcome of drug reaction with eosinophilia and systemic symptoms (DRESS) in children: a scoping review.
    Clin Exp Dermatol. 2025;50:408-411.
    >> Share


    Cutis

  51. WANG J, Derrick KM, Heilman E, Jagdeo J, et al
    Successful Treatment of Severe Dystrophic Nail Psoriasis With Deucravacitinib.
    Cutis. 2024;114:196-198.
    >> Share

  52. MCGUIRT V, Wang Y, Feldman SR
    Optimal Exercise Levels for Dermatology Patients With Psoriasis.
    Cutis. 2024;114:E4-E5.
    >> Share

  53. ANTHONY MR, Farkouh C, Abdi P, Khan QA, et al
    Buruli Ulcer Transmission: Environmental Pathways and Implications for Dermatologic Care.
    Cutis. 2024;114:184-186.
    >> Share

  54. LU C, Fan Y, Du Y, Bi L, et al
    Clinical, Laboratory, and Trichoscopic Features of Pediatric Androgenetic Alopecia.
    Cutis. 2024;114:191-195.
    >> Share


    Int J Cancer

  55. NALWOGA A, Jackson C, Fiorillo S, Manyeruke F, et al
    Evaluation of plasma alpha-1-antichymotrypsin as a marker for pulmonary Kaposi sarcoma.
    Int J Cancer. 2025 Jan 30. doi: 10.1002/ijc.35351.
    >> Share


    Int J Dermatol

  56. KEMENY L
    Editor's Highlights-February 2025.
    Int J Dermatol. 2025;64:223-224.
    >> Share

  57. GANDARILLAS S, Berger A, Stephenson R, Mehregan D, et al
    Enriched class II HLA inherence in patients with checkpoint inhibitor-associated bullous pemphigoid.
    Int J Dermatol. 2025;64:399-401.
    >> Share

  58. WATANABE H, Takahagi S, Hayama K, Fukunaga A, et al
    Prognosis of chronic spontaneous urticaria with an inadequate response to omalizumab.
    Int J Dermatol. 2025;64:349-358.
    >> Share

  59. WANG Y, Li S, Li Z, Jing K, et al
    Clinical and immunoserological characteristics of anti-p200 pemphigoid: Comparisons of patients with epitope spreading and non-epitope spreading.
    Int J Dermatol. 2025;64:359-366.
    >> Share

  60. SINGH S, Chatterjee D, De D, Mahajan R, et al
    Solitary verrucous plaque on a leg.
    Int J Dermatol. 2025;64:316-318.
    >> Share

  61. LAPIDUS AH, Lee S, Khandewal T, Liu ZF, et al
    Subcutaneous granuloma annulare: a systematic review of a rare and underdiagnosed disease.
    Int J Dermatol. 2025;64:246-255.
    >> Share

  62. MALHI K, Chatterjee D, Mahajan R, Handa S, et al
    Direct immunofluorescence on plucked hair outer root sheath can predict relapse in pemphigus vulgaris.
    Int J Dermatol. 2025;64:367-376.
    >> Share

  63. CACCIAPUOTI S, Potestio L, Gallo L, Musumeci ML, et al
    Short-term efficacy of tildrakizumab on difficult-to-treat areas: a real-world experience.
    Int J Dermatol. 2025;64:319-324.
    >> Share

  64. GKINI MA, Nakamura M, Alexis AF, Londono-Garcia A, et al
    Psoriasis in People With Skin of Color: An Evidence-Based Update.
    Int J Dermatol. 2025 Jan 31. doi: 10.1111/ijd.17651.
    >> Share


    J Dermatol

  65. HAGINO T, Onda M, Saeki H, Fujimoto E, et al
    Real-world 52-week effectiveness of deucravacitinib in psoriasis: A stratified analysis by age and body mass index.
    J Dermatol. 2025 Jan 28. doi: 10.1111/1346-8138.17617.
    >> Share

  66. MORITO K, Kado S, Okada H, Sato A, et al
    Cutaneous squamous carcinoma with pulmonary metastasis with cavity formation successfully treated with nivolumab.
    J Dermatol. 2025 Jan 29. doi: 10.1111/1346-8138.17649.
    >> Share


    J Invest Dermatol

  67. NASSIR S, Yousif M, Li X, Severson KJ, et al
    Multi-omic Sequencing of Intermediate to High-Risk Cutaneous Squamous Cell Carcinoma Identifies Critical Genes and Expression Patterns Associated with Disease and Poor Outcomes.
    J Invest Dermatol. 2025 Jan 28:S0022-202X(25)00082.
    >> Share

  68. ABUABARA K, Kidd SA, Ye M, Tully J, et al
    The impact of childhood stressful life events on atopic dermatitis disease activity and severity.
    J Invest Dermatol. 2025 Jan 28:S0022-202X(25)00081.
    >> Share

  69. CAVES E, Jussila A, Forni MF, Benvie A, et al
    Atgl-dependent adipocyte lipolysis promotes lipodystrophy and restrains fibrogenic responses during skin fibrosis.
    J Invest Dermatol. 2025 Jan 20:S0022-202X(25)00022.
    >> Share

  70. MORIOKA N, Ganier C, Watt FM
    Fetal fibroblast heterogeneity defines dermal architecture during human embryonic skin development.
    J Invest Dermatol. 2025 Jan 27:S0022-202X(25)00077.
    >> Share

  71. NAVSARIA LJ, Li Y, Jambusaria A, Wheless LE, et al
    Internal cancers in solid organ transplant recipients with a post-transplant skin cancer: a cohort study.
    J Invest Dermatol. 2025 Jan 24:S0022-202X(25)00030.
    >> Share


    Mycoses

  72. XIHUA Y, Xiaofeng Q, Lulu T, Zhiyu K, et al
    Fungal Skin Disease Incidence, Prevalence and Disability-Adjusted Life Years in Four Asian Countries (1990-2019).
    Mycoses. 2025;68:e70004.
    >> Share

  73. DIONGUE K, Diallo MA, Diop A, Seck MC, et al
    Adult With Tinea Capitis: A Five-Year (2015-2019) Trend Study Among Patients Attending the Aristide Le Dantec University Hospital in Dakar, Senegal.
    Mycoses. 2025;68:e70030.
    >> Share


    N Engl J Med

  74. COHN DM, Gurugama P, Magerl M, Katelaris CH, et al
    CRISPR-Based Therapy for Hereditary Angioedema.
    N Engl J Med. 2025;392:458-467.
    >> Share

  75. EIKA F, Al-Saad S
    Endobronchial Kaposi's Sarcoma.
    N Engl J Med. 2025;392:e15.
    >> Share


    Nat Rev Cancer

  76. BREWER G
    Allies in the epidermis.
    Nat Rev Cancer. 2025 Jan 30. doi: 10.1038/s41568-025-00793.
    >> Share


    Plast Reconstr Surg

  77. KIM M, Vingan P, Boe LA, Mehrara BJ, et al
    Satisfaction with Breasts following Autologous Reconstruction: Assessing Associated Factors and the Impact of Revisions.
    Plast Reconstr Surg. 2025;155:235-244.
    >> Share

  78. RANNIKKO EH, Pajula S, Suominen SH, Kiiski J, et al
    Phase II Study Shows the Effect of Adenoviral Vascular Endothelial Growth Factor C and Lymph Node Transfer in Lymphedema.
    Plast Reconstr Surg. 2025;155:256e-267e.
    >> Share

  79. KEANE AM, Tandon D, Tenenbaum MM, Myckatyn TM, et al
    Expanded Approaches for Mastopexy in Aesthetic and Reconstructive Breast Surgery.
    Plast Reconstr Surg. 2025;155:433e-446e.
    >> Share


    PLoS One

  80. JARAB AS, Al-Qerem W, Alzoubi KH, Al Mohammad M, et al
    Public knowledge, attitudes, practices, and barriers to skin cancer screening in the United Arab Emirates.
    PLoS One. 2025;20:e0316613.
    >> Share

  81. LIU X, Yang T, Yao J
    Impact of digital breast tomosynthesis on screening performance and interval cancer rates compared to digital mammography: A meta-analysis.
    PLoS One. 2025;20:e0315466.
    >> Share

  82. DEMEKE AD, Deribe B, Girma M, Gizaw M, et al
    Screening attendance of breast or cervical cancers and its associated factors among 30-49 year old women in Gedeo zone, South Ethiopia: Cross-sectional study.
    PLoS One. 2025;20:e0315891.
    >> Share

  83. UM S, Sopheab H
    Breast and cervical cancer screening among women at reproductive age in Cambodia: A secondary analysis of Cambodia Demographic and Health Survey 2022.
    PLoS One. 2025;20:e0295881.
    >> Share

  84. HUGDAHL E, Aziz S, Klingen TA, Akslen LA, et al
    Prognostic value of immune biomarkers in melanoma loco-regional metastases.
    PLoS One. 2025;20:e0315284.
    >> Share

  85. GALVAO DE OLIVEIRA ML, Leon-Morillas F, Andriola IC, Gomez Martinez CS, et al
    Venous leg ulcer healing as a determinant of quality of life in patients treated with unna boot: A quasi-experimental study.
    PLoS One. 2025;20:e0314490.
    >> Share

  86. ELKAEED EB, Elkady H, Khattab AM, Yousef RG, et al
    Integrated in silico and in vitro exploration of the anti-VEGFR-2 activities of a semisynthetic xanthine alkaloid inhibiting breast cancer.
    PLoS One. 2025;20:e0316146.
    >> Share

  87. SASAKI T, Teraguchi M, Mure K, Asai Y, et al
    Prevalence of accessory navicular in Japanese children: A cross-sectional study using ultrasound-Katsuragi Integrated Defense for Locomotive Syndrome in children study.
    PLoS One. 2025;20:e0318014.
    >> Share

  88. GAO Y, Liang G, Chang C, Pan F, et al
    Analysis of cervical and breast cancer screening behavior and its influencing factors among urban and rural women in Beijing.
    PLoS One. 2025;20:e0316898.
    >> Share

  89. LI B, Liu J, Zhang Y, Yang W, et al
    Comparative readability of information on different treatment options for breast cancer, based on WeChat public accounts.
    PLoS One. 2025;20:e0317032.
    >> Share

  90. PAZMINO FA, Parra-Munoz M, Saavedra CH, Muvdi-Arenas S, et al
    Mucosal leishmaniasis is associated with the Leishmania RNA virus and inappropriate cutaneous leishmaniasis treatment.
    PLoS One. 2025;20:e0317221.
    >> Share


    Proc Natl Acad Sci U S A

  91. LEI L, Song Y, Yang L, Wang Y, et al
    Triethylamine-mediated protonation-deprotonation unlocks dual-drug self assembly to suppress breast cancer progression and metastasis.
    Proc Natl Acad Sci U S A. 2025;122:e2416796122.
    >> Share

  92. KRAKOWIAK PA, Flores ME, Cuddy SR, Whitford AL, et al
    Co-option of mitochondrial nucleic acid-sensing pathways by HSV-1 UL12.5 for reactivation from latent infection.
    Proc Natl Acad Sci U S A. 2025;122:e2413965122.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016